Clear Lensectomy with Hydrus Stent in Black and Afro-Latino Patients: A 1-Year Retrospective Study
Table 2
Primary outcome measures—IOP, CDVA, number of medications, and mean deviation on visual field at preoperative and follow-up visits for all patients.
Timepoint
IOP (mmHg)
Ocular hypotensive medications
CDVA
Visual field test
N
Mean ± SD
value
N
Mean ± SD
value
LogMAR (mean ± SD)
value
Mean deviation ± SD (dB)
Preoperative
134
14.4 ± 3.9
—
134
2.5 ± 1.4
—
0.12 ± 0.04
—
−8.28 ± 7.26
Postoperative day 1
132
11.9 ± 4.7
<0.00010
—
—
—
—
—
—
1 month
132
14.6 ± 4.90
0.71
132
0.13 ± 0.63
<0.00010
0.11 ± 0.2
<0.00010
—
3 months
114
13.1 ± 2.90
0.0025
115
0.38 ± 0.94
<0.00010
0.08 ± 0.19
<0.00010
—
6 months
111
13.1 ± 2.80
0.0027
111
0.42 ± 1.03
<0.00010
0.09 ± 0.2
<0.00010
—
1 year
134
13.8 ± 3.10
0.16
134
0.43 ± 1.04
<0.00010
0.09 ± 0.2
<0.00010
−8.28 ± 7.70 (> 0.99)
CDVA, corrected distance visual acuity; IOP, intraocular pressure; N, number of patients; SD, standard deviation. values are statistically significant.
